Skip to Content

Drotrecogin alfa Pregnancy and Breastfeeding Warnings

Drotrecogin alfa is also known as: Xigris

Drotrecogin alfa Pregnancy Warnings

Drotrecogin alfa has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Drotrecogin alfa is only recommended for use during pregnancy when benefit outweighs risk.

See references

Drotrecogin alfa Breastfeeding Warnings

There are no data on the excretion of drotrecogin alfa into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Xigris (drotrecogin alfa)." Lilly, Eli and Company, Indianapolis, IN.

References for breastfeeding information

  1. "Product Information. Xigris (drotrecogin alfa)." Lilly, Eli and Company, Indianapolis, IN.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide